The global antidiarrheal microorganisms market, valued at USD 1.45 billion in 2025, is projected to reach USD 2.67 billion by 2034, growing at a CAGR of 7.8%. Growth is driven by rising gastrointestinal disorders, increasing antibiotic-associated diarrhea cases, and growing adoption of probiotic-based therapies for effective microbiome restoration.
Read MoreThe global activated charcoal capsules market, valued at USD 345.7 million in 2025, is projected to reach USD 598.2 million by 2034, growing at a CAGR of 6.1%. Growth is driven by rising demand for natural detox solutions, increasing digestive health awareness, and expanding applications in both wellness supplements and medical treatments.
Read MoreDiscover Ayaansh Hospital, the Best IVF Centre in Bangalore, offering advanced Fertility treatment in Bangalore, expert care, and high success rates.
Read MoreThe global chemical medicines market, valued at USD 73.23 billion in 2024, is projected to reach USD 105 billion by 2034, growing at a CAGR of 5.4%. Growth is driven by rising chronic disease prevalence, advancements in drug delivery technologies, and increasing demand for innovative formulations across multiple therapeutic areas.
Read MoreThe global Degarelix market, valued at USD 320 million in 2024, is projected to reach USD 520 million by 2034, growing at a CAGR of 5.8%. Growth is driven by rising prostate cancer incidence, increasing adoption of advanced hormonal therapies, and expanding treatment access across emerging healthcare markets.
Read More